Proteins from the DNA damage response: Regulation, dysfunction, and anticancer strategies

C Molinaro, A Martoriati, K Cailliau - Cancers, 2021 - mdpi.com
Simple Summary Cells respond to genotoxic stress through complex protein pathways
called DNA damage response (DDR). These mechanisms ensure the preservation of …

Genome instability in multiple myeloma: Facts and factors

AY Aksenova, AS Zhuk, AG Lada, IV Zotova… - Cancers, 2021 - mdpi.com
Simple Summary Multiple myeloma is an incurable blood cancer caused by the malignant
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …

Functionalized nanomaterials-based electrochemiluminescent biosensors and their application in cancer biomarkers detection

L Yang, X Gu, J Liu, L Wu, Y Qin - Talanta, 2024 - Elsevier
To detect a range of trace biomarkers associated with human diseases, researchers have
been focusing on developing biosensors that possess high sensitivity and specificity …

Circulating tumour cells, cell free DNA and tumour-educated platelets as reliable prognostic and management biomarkers for the liquid biopsy in multiple myeloma

A Allegra, G Cancemi, G Mirabile, A Tonacci… - Cancers, 2022 - mdpi.com
Simple Summary Even though the presently employed biomarkers in the detection and
management of multiple myeloma are demonstrating encouraging results, the mortality …

[HTML][HTML] Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders

S Mithraprabhu, M Chen, I Savvidou, A Reale… - Leukemia, 2021 - nature.com
Liquid biopsies—a source of circulating cell-free nucleic acids, proteins and extracellular
vesicles—are currently being explored for the quantitative and qualitative characterisation of …

Electrochemiluminescent/Electrochemical ratiometric biosensor for extremely specific and ultrasensitive detection of circulating tumor DNA

L Yang, X Zhou, K Zhang, J Liu, L Zhao, A Cai… - Sensors and Actuators B …, 2023 - Elsevier
Abstract Herein, an electrochemiluminescent (ECL)/electrochemical (EC) ratiometric
biosensor was developed for the ultrasensitive determination of circulating tumor DNA …

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma

S Mithraprabhu, J Reynolds, R Turner, H Quach… - Blood Cancer …, 2023 - nature.com
Dear Editor, Multiple myeloma (MM), an incurable plasma cell malignancy, is the second
most common form of blood cancer with a 5-year overall survival (OS) of 48.5% for newly …

Human myeloma cell‐and plasma‐derived extracellular vesicles contribute to functional regulation of stromal cells

A Reale, I Carmichael, R Xu, S Mithraprabhu… - …, 2021 - Wiley Online Library
Circulating small extracellular vesicles (sEV) represent promising non‐invasive biomarkers
that may aid in the diagnosis and risk‐stratification of multiple myeloma (MM), an incurable …

Clinical significance of circulating cell-free DNA detection in multiple myeloma: a meta-analysis

X Ye, W Li, L Zhang, J Yu - Frontiers in Oncology, 2022 - frontiersin.org
Circulating cell-free DNA (cfDNA) detection, a non-invasive method, appears promising for
genetic analyses as well as quantitative assessment of tumor burden in patients with cancer …

Measurable residual disease in peripheral blood in myeloma: dream or reality

T Kubicki, BA Derman, D Dytfeld… - Current Opinion in …, 2023 - journals.lww.com
Measurable residual disease in peripheral blood in myeloma:... : Current Opinion in Oncology
Measurable residual disease in peripheral blood in myeloma: dream or reality : Current Opinion …